Patient and caregiver in flower nursery
Patient and caregiver in flower nursery

Start LEQEMBI®. Change the course of AD1,2

In an 18-month study, LEQEMBI was proven to slow the progression of MCI due to AD and mild AD dementia. Learn more:

MCI=mild cognitive impairment.

The Centers for Medicare & Medicaid Services (CMS) has released information regarding coverage of new Alzheimer’s drugs for Medicare patients. For more information, click below.

To learn about Eisai Patient Support for patients prescribed LEQEMBI, call 1-833-4-LEQEMBI (1-833-453-7362) or click here.

Eisai patient support logo